Skip to main content
. 2022 Sep 2;14(9):1856. doi: 10.3390/pharmaceutics14091856

Figure 2.

Figure 2

(A) The Cα RMSD of GPR97 in the BCM–GPR97 (purple), BCM–GPR97–Go (red), BCM–GPR97–palmitoylated Go (yellow), cortisol–GPR97 (blue), cortisol–GPR97–Go (pink), and cortisol–GPR97–palmitoylated Go (green) systems in 1000 ns MD simulations. (B) The Cα RMSF of GPR97 in BCM–GPR97 (purple), BCM–GPR97–Go (red), BCM–GPR97–palmitoylated Go (yellow), cortisol–GPR97 (blue), cortisol–GPR97–Go (pink), and cortisol–GPR97–palmitoylated Go (green) systems in 1000 ns MD simulations (residues 464–472 are ICL3).